Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Bio-Rad Labs (BIO) Tops Q3 EPS by 11c
November 1, 2016 5:15 PM EDTBio-Rad Labs (NYSE: BIO) reported Q3 EPS of $0.62, $0.11 better than the analyst estimate of $0.51. Revenue for the quarter came in at $508.7 million versus the consensus estimate of $480.6 million.
"We are pleased with a strong sales performance in the third quarter, in particular, our life science... More



